CliffBio
small molecule

CUPRIC CHLORIDE

CUPRIC CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyExela Pharma Sciences Llc →See this company's full patent-cliff portfolio

Drug detail

Brand nameCUPRIC CHLORIDE
Active ingredientCUPRIC CHLORIDE
StrengthEQ 0.4MG COPPER/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 2022
Marketing statusRX

More from Exela Pharma Sciences Llc

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CUPRIC CHLORIDE patent cliff — loss of exclusivity — | CliffBio